First-line avelumab shows clinical activity in advanced urothelial carcinoma Presented ByDr Roberto Iacovelli, Catholic University of Rome, Italy TrialPhase 2, ARIES ConferenceASCO GU 2022 8 April, 2022 11:17
Urothelial cancer: avelumab works as maintenance therapy ExpertProf. Thomas Powles, Barts Cancer Institute, UK TrialPhase 3, JAVELIN Bladder 100 ConferenceASCO 2020 17 September, 2020 14:30
